Speaker Survey

Dr. Thomas J. Raedler

Question Title

* 1. The session met the stated learning objectives

	1 Learning objective not met	2	3 Learning objective partially met	4	5 Learning objective met
Learning Objective 1:Better understanding of newly approved psychotropic medications	Learning Objective 1:Better understanding of newly approved psychotropic medications 1 Learning objective not met	Learning Objective 1:Better understanding of newly approved psychotropic medications 2	Learning Objective 1:Better understanding of newly approved psychotropic medications 3 Learning objective partially met	Learning Objective 1:Better understanding of newly approved psychotropic medications 4	Learning Objective 1:Better understanding of newly approved psychotropic medications 5 Learning objective met
Learning Objective 2: Better understanding of new indications for previously approved psychotropic medications	Learning Objective 2: Better understanding of new indications for previously approved psychotropic medications 1 Learning objective not met	Learning Objective 2: Better understanding of new indications for previously approved psychotropic medications 2	Learning Objective 2: Better understanding of new indications for previously approved psychotropic medications 3 Learning objective partially met	Learning Objective 2: Better understanding of new indications for previously approved psychotropic medications 4	Learning Objective 2: Better understanding of new indications for previously approved psychotropic medications 5 Learning objective met
Learning Objective 3: Better understanding of existing pharmacological treatment-challenges	Learning Objective 3: Better understanding of existing pharmacological treatment-challenges 1 Learning objective not met	Learning Objective 3: Better understanding of existing pharmacological treatment-challenges 2	Learning Objective 3: Better understanding of existing pharmacological treatment-challenges 3 Learning objective partially met	Learning Objective 3: Better understanding of existing pharmacological treatment-challenges 4	Learning Objective 3: Better understanding of existing pharmacological treatment-challenges 5 Learning objective met

Question Title

* 2. On a scale from 1 (not at all relevant) to 5 (extremely relevant), please rate how relevant this presentation is to you. By relevance, we mean how appropriate the topic and effective the speaker is for you.

1-Not at all relevant

5-Extremely relevant

1-Not at all relevant

5-Extremely relevant

Additional comments:

Question Title

* 3. On a scale from 1 (no opportunity) to 5 (outstanding opportunity for discussion and interaction), please rate how interactive this presentation was for you. By interaction we mean discussion, questions and engagement with the presenter and the topic.

1- No opportunity

5-Outstanding opportunity for discussion and interaction

1- No opportunity

5-Outstanding opportunity for discussion and interaction

Additional Comments:

Question Title

* 1. The session met the stated learning objectives

Question Title

* 2. On a scale from 1 (not at all relevant) to 5 (extremely relevant), please rate how relevant this presentation is to you. By relevance, we mean how appropriate the topic and effective the speaker is for you.

Question Title

* 3. On a scale from 1 (no opportunity) to 5 (outstanding opportunity for discussion and interaction), please rate how interactive this presentation was for you. By interaction we mean discussion, questions and engagement with the presenter and the topic.

Question Title

* 4. Please provide us with any additional comments or observations you would like us to be aware of.